P925: PHASE 1 TRIAL OF ANTI-CD38 MONOCLONAL ANTIBODY CM313 IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA OR LYMPHOMA

• Wenming Chen,
• Zhongxia Huang,
• Baijun Fang,
• Yuqin Song,
• Hongmei Jing,
• Zhongjun Xia,
• Zhen Cai,
• Gang An,
• Huixing Zhou,
• Nian Liu,
• Xin LI,
• Yuzhang Liu,
• Lingyan Ping,
• Wei Wan,
• Xiaoqin Chen,
• Jingsong He,
• Yan Xu

Affiliations

Wenming Chen

1 Beijing Chaoyang Hospital, Capital Medical University, Department of Hematology, Beijing, China

Zhongxia Huang

1 Beijing Chaoyang Hospital, Capital Medical University, Department of Hematology, Beijing, China

Baijun Fang

2 Henan Cancer Hospital, Ward 5, Department of Hematology, Zhengzhou, China

Yuqin Song

3 Beijing Cancer Hospital, Department of Lymphoma, Beijing, China

Hongmei Jing

4 Peking University Third Hospital, Department of Hematology, Beijing, China

Zhongjun Xia

5 Sun Yat-sen University Cancer Center, Department of Hematology, Guangzhou, China

Zhen Cai

6 The First Affiliated Hospital, Zhejiang University School of Medicine, Department of Hematology, Huangzhou, China

Gang An

7 Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College Hospital, Center of Lymphoma Diagnosis and Treatment, Tianjin, China

Huixing Zhou

1 Beijing Chaoyang Hospital, Capital Medical University, Department of Hematology, Beijing, China

Nian Liu

1 Beijing Chaoyang Hospital, Capital Medical University, Department of Hematology, Beijing, China

Xin LI

1 Beijing Chaoyang Hospital, Capital Medical University, Department of Hematology, Beijing, China

Yuzhang Liu

2 Henan Cancer Hospital, Ward 5, Department of Hematology, Zhengzhou, China

Lingyan Ping

3 Beijing Cancer Hospital, Department of Lymphoma, Beijing, China

Wei Wan

4 Peking University Third Hospital, Department of Hematology, Beijing, China

Xiaoqin Chen

5 Sun Yat-sen University Cancer Center, Department of Hematology, Guangzhou, China

Jingsong He

6 The First Affiliated Hospital, Zhejiang University School of Medicine, Department of Hematology, Huangzhou, China

Yan Xu

7 Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College Hospital, Center of Lymphoma Diagnosis and Treatment, Tianjin, China